Clinical Trials
19 trialsNCT07557225 2026-05-14
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Peking University First Hospital
Phase NA Recruiting
NCT06195150 2026-05-11
ITHORinVHL
IRCCS San Raffaele
Active not recruiting
NCT03050268 2026-04-23
SJFAMILY
St. Jude Children's Research Hospital
Recruiting
NCT06573723 2026-01-14
Institutional Registry of Rare Diseases
Hospital Italiano de Buenos Aires
Recruiting
NCT07327164 2026-01-09
Precision Medicine for Neurocutaneous Syndromes in Western China
West China Hospital
Completed
NCT07167329 2025-09-11
BELIEVE-VHL
AC Camargo Cancer Center
Phase 2 Recruiting
NCT06523582 2024-07-26
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Universidad Nacional Autonoma de Mexico
Recruiting
NCT00330564 2024-06-27
Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00970970 2024-05-06
VHLimage
University Medical Center Groningen
Completed
NCT06391879 2024-04-30
Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma
Peking University First Hospital
Unknown
NCT03749980 2024-04-26
MyVHL
VHL Alliance
Recruiting
NCT06194669 2024-01-10
SoMuKT
IRCCS San Raffaele
Recruiting
NCT05424016 2023-12-13
PRO-HEB
Assistance Publique - Hôpitaux de Paris
Phase NA Recruiting
NCT05534854 2023-08-31
Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes
RenJi Hospital
Unknown
NCT03001349 2021-02-15
68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Terminated
NCT03979833 2019-09-27
Drivers of Hypoxia-induced Angiogenesis in Tumor Development
University of Copenhagen
Unknown
NCT02420067 2017-05-09
Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients
University of Copenhagen
Recruiting
NCT01266070 2017-02-13
TKI 258 in Von Hippel-Lindau Syndrome (VHL)
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01015300 2012-05-11
Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease
Dartmouth-Hitchcock Medical Center
Phase EARLY_PHASE1 Terminated